Request for Covid-19 Impact Assessment of this Report
The United States Levonorgestrel API market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Levonorgestrel API market, reaching US$ million by the year 2028. As for the Europe Levonorgestrel API landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Levonorgestrel API players cover ScinoPharm, Altaris (3M Drug Delivery Systems), Bayer, and Cipla, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Levonorgestrel API market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Short-Acting Contraceptive API
Long-Acting Contraceptive API
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Table
Mixture Products
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
ScinoPharm
Altaris (3M Drug Delivery Systems)
Bayer
Cipla
Formos
FORTEQ NIDAU AG
Gedeon Richter
Hangzhou Longshine Bio-Tec
Hubei Gedian Humanwell Pharmaceutical
Indo Phyto Chemicals
Industriale Chimica
Jenapharm
Lupin
Naari
Qinhuangdao Zizhu Pharmaceutical
Sterling Chemical Malta Ltd
Symbiotec Pharmalab
Yangzhou Pharmaceutical
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Levonorgestrel API Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Levonorgestrel API by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Levonorgestrel API by Country/Region, 2017, 2022 & 2028
2.2 Levonorgestrel API Segment by Type
2.2.1 Short-Acting Contraceptive API
2.2.2 Long-Acting Contraceptive API
2.3 Levonorgestrel API Sales by Type
2.3.1 Global Levonorgestrel API Sales Market Share by Type (2017-2022)
2.3.2 Global Levonorgestrel API Revenue and Market Share by Type (2017-2022)
2.3.3 Global Levonorgestrel API Sale Price by Type (2017-2022)
2.4 Levonorgestrel API Segment by Application
2.4.1 Table
2.4.2 Mixture Products
2.4.3 Other
2.5 Levonorgestrel API Sales by Application
2.5.1 Global Levonorgestrel API Sale Market Share by Application (2017-2022)
2.5.2 Global Levonorgestrel API Revenue and Market Share by Application (2017-2022)
2.5.3 Global Levonorgestrel API Sale Price by Application (2017-2022)
3 Global Levonorgestrel API by Company
3.1 Global Levonorgestrel API Breakdown Data by Company
3.1.1 Global Levonorgestrel API Annual Sales by Company (2020-2022)
3.1.2 Global Levonorgestrel API Sales Market Share by Company (2020-2022)
3.2 Global Levonorgestrel API Annual Revenue by Company (2020-2022)
3.2.1 Global Levonorgestrel API Revenue by Company (2020-2022)
3.2.2 Global Levonorgestrel API Revenue Market Share by Company (2020-2022)
3.3 Global Levonorgestrel API Sale Price by Company
3.4 Key Manufacturers Levonorgestrel API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Levonorgestrel API Product Location Distribution
3.4.2 Players Levonorgestrel API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Levonorgestrel API by Geographic Region
4.1 World Historic Levonorgestrel API Market Size by Geographic Region (2017-2022)
4.1.1 Global Levonorgestrel API Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Levonorgestrel API Annual Revenue by Geographic Region
4.2 World Historic Levonorgestrel API Market Size by Country/Region (2017-2022)
4.2.1 Global Levonorgestrel API Annual Sales by Country/Region (2017-2022)
4.2.2 Global Levonorgestrel API Annual Revenue by Country/Region
4.3 Americas Levonorgestrel API Sales Growth
4.4 APAC Levonorgestrel API Sales Growth
4.5 Europe Levonorgestrel API Sales Growth
4.6 Middle East & Africa Levonorgestrel API Sales Growth
5 Americas
5.1 Americas Levonorgestrel API Sales by Country
5.1.1 Americas Levonorgestrel API Sales by Country (2017-2022)
5.1.2 Americas Levonorgestrel API Revenue by Country (2017-2022)
5.2 Americas Levonorgestrel API Sales by Type
5.3 Americas Levonorgestrel API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Levonorgestrel API Sales by Region
6.1.1 APAC Levonorgestrel API Sales by Region (2017-2022)
6.1.2 APAC Levonorgestrel API Revenue by Region (2017-2022)
6.2 APAC Levonorgestrel API Sales by Type
6.3 APAC Levonorgestrel API Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Levonorgestrel API by Country
7.1.1 Europe Levonorgestrel API Sales by Country (2017-2022)
7.1.2 Europe Levonorgestrel API Revenue by Country (2017-2022)
7.2 Europe Levonorgestrel API Sales by Type
7.3 Europe Levonorgestrel API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Levonorgestrel API by Country
8.1.1 Middle East & Africa Levonorgestrel API Sales by Country (2017-2022)
8.1.2 Middle East & Africa Levonorgestrel API Revenue by Country (2017-2022)
8.2 Middle East & Africa Levonorgestrel API Sales by Type
8.3 Middle East & Africa Levonorgestrel API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Levonorgestrel API
10.3 Manufacturing Process Analysis of Levonorgestrel API
10.4 Industry Chain Structure of Levonorgestrel API
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Levonorgestrel API Distributors
11.3 Levonorgestrel API Customer
12 World Forecast Review for Levonorgestrel API by Geographic Region
12.1 Global Levonorgestrel API Market Size Forecast by Region
12.1.1 Global Levonorgestrel API Forecast by Region (2023-2028)
12.1.2 Global Levonorgestrel API Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Levonorgestrel API Forecast by Type
12.7 Global Levonorgestrel API Forecast by Application
13 Key Players Analysis
13.1 ScinoPharm
13.1.1 ScinoPharm Company Information
13.1.2 ScinoPharm Levonorgestrel API Product Offered
13.1.3 ScinoPharm Levonorgestrel API Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 ScinoPharm Main Business Overview
13.1.5 ScinoPharm Latest Developments
13.2 Altaris (3M Drug Delivery Systems)
13.2.1 Altaris (3M Drug Delivery Systems) Company Information
13.2.2 Altaris (3M Drug Delivery Systems) Levonorgestrel API Product Offered
13.2.3 Altaris (3M Drug Delivery Systems) Levonorgestrel API Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Altaris (3M Drug Delivery Systems) Main Business Overview
13.2.5 Altaris (3M Drug Delivery Systems) Latest Developments
13.3 Bayer
13.3.1 Bayer Company Information
13.3.2 Bayer Levonorgestrel API Product Offered
13.3.3 Bayer Levonorgestrel API Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Bayer Main Business Overview
13.3.5 Bayer Latest Developments
13.4 Cipla
13.4.1 Cipla Company Information
13.4.2 Cipla Levonorgestrel API Product Offered
13.4.3 Cipla Levonorgestrel API Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Cipla Main Business Overview
13.4.5 Cipla Latest Developments
13.5 Formos
13.5.1 Formos Company Information
13.5.2 Formos Levonorgestrel API Product Offered
13.5.3 Formos Levonorgestrel API Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Formos Main Business Overview
13.5.5 Formos Latest Developments
13.6 FORTEQ NIDAU AG
13.6.1 FORTEQ NIDAU AG Company Information
13.6.2 FORTEQ NIDAU AG Levonorgestrel API Product Offered
13.6.3 FORTEQ NIDAU AG Levonorgestrel API Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 FORTEQ NIDAU AG Main Business Overview
13.6.5 FORTEQ NIDAU AG Latest Developments
13.7 Gedeon Richter
13.7.1 Gedeon Richter Company Information
13.7.2 Gedeon Richter Levonorgestrel API Product Offered
13.7.3 Gedeon Richter Levonorgestrel API Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Gedeon Richter Main Business Overview
13.7.5 Gedeon Richter Latest Developments
13.8 Hangzhou Longshine Bio-Tec
13.8.1 Hangzhou Longshine Bio-Tec Company Information
13.8.2 Hangzhou Longshine Bio-Tec Levonorgestrel API Product Offered
13.8.3 Hangzhou Longshine Bio-Tec Levonorgestrel API Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Hangzhou Longshine Bio-Tec Main Business Overview
13.8.5 Hangzhou Longshine Bio-Tec Latest Developments
13.9 Hubei Gedian Humanwell Pharmaceutical
13.9.1 Hubei Gedian Humanwell Pharmaceutical Company Information
13.9.2 Hubei Gedian Humanwell Pharmaceutical Levonorgestrel API Product Offered
13.9.3 Hubei Gedian Humanwell Pharmaceutical Levonorgestrel API Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Hubei Gedian Humanwell Pharmaceutical Main Business Overview
13.9.5 Hubei Gedian Humanwell Pharmaceutical Latest Developments
13.10 Indo Phyto Chemicals
13.10.1 Indo Phyto Chemicals Company Information
13.10.2 Indo Phyto Chemicals Levonorgestrel API Product Offered
13.10.3 Indo Phyto Chemicals Levonorgestrel API Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Indo Phyto Chemicals Main Business Overview
13.10.5 Indo Phyto Chemicals Latest Developments
13.11 Industriale Chimica
13.11.1 Industriale Chimica Company Information
13.11.2 Industriale Chimica Levonorgestrel API Product Offered
13.11.3 Industriale Chimica Levonorgestrel API Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Industriale Chimica Main Business Overview
13.11.5 Industriale Chimica Latest Developments
13.12 Jenapharm
13.12.1 Jenapharm Company Information
13.12.2 Jenapharm Levonorgestrel API Product Offered
13.12.3 Jenapharm Levonorgestrel API Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Jenapharm Main Business Overview
13.12.5 Jenapharm Latest Developments
13.13 Lupin
13.13.1 Lupin Company Information
13.13.2 Lupin Levonorgestrel API Product Offered
13.13.3 Lupin Levonorgestrel API Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Lupin Main Business Overview
13.13.5 Lupin Latest Developments
13.14 Naari
13.14.1 Naari Company Information
13.14.2 Naari Levonorgestrel API Product Offered
13.14.3 Naari Levonorgestrel API Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Naari Main Business Overview
13.14.5 Naari Latest Developments
13.15 Qinhuangdao Zizhu Pharmaceutical
13.15.1 Qinhuangdao Zizhu Pharmaceutical Company Information
13.15.2 Qinhuangdao Zizhu Pharmaceutical Levonorgestrel API Product Offered
13.15.3 Qinhuangdao Zizhu Pharmaceutical Levonorgestrel API Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Qinhuangdao Zizhu Pharmaceutical Main Business Overview
13.15.5 Qinhuangdao Zizhu Pharmaceutical Latest Developments
13.16 Sterling Chemical Malta Ltd
13.16.1 Sterling Chemical Malta Ltd Company Information
13.16.2 Sterling Chemical Malta Ltd Levonorgestrel API Product Offered
13.16.3 Sterling Chemical Malta Ltd Levonorgestrel API Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Sterling Chemical Malta Ltd Main Business Overview
13.16.5 Sterling Chemical Malta Ltd Latest Developments
13.17 Symbiotec Pharmalab
13.17.1 Symbiotec Pharmalab Company Information
13.17.2 Symbiotec Pharmalab Levonorgestrel API Product Offered
13.17.3 Symbiotec Pharmalab Levonorgestrel API Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Symbiotec Pharmalab Main Business Overview
13.17.5 Symbiotec Pharmalab Latest Developments
13.18 Yangzhou Pharmaceutical
13.18.1 Yangzhou Pharmaceutical Company Information
13.18.2 Yangzhou Pharmaceutical Levonorgestrel API Product Offered
13.18.3 Yangzhou Pharmaceutical Levonorgestrel API Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 Yangzhou Pharmaceutical Main Business Overview
13.18.5 Yangzhou Pharmaceutical Latest Developments
14 Research Findings and Conclusion
Table 1. Levonorgestrel API Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Levonorgestrel API Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Short-Acting Contraceptive API
Table 4. Major Players of Long-Acting Contraceptive API
Table 5. Global Levonorgestrel API Sales by Type (2017-2022) & (KG)
Table 6. Global Levonorgestrel API Sales Market Share by Type (2017-2022)
Table 7. Global Levonorgestrel API Revenue by Type (2017-2022) & ($ million)
Table 8. Global Levonorgestrel API Revenue Market Share by Type (2017-2022)
Table 9. Global Levonorgestrel API Sale Price by Type (2017-2022) & (US$/G)
Table 10. Global Levonorgestrel API Sales by Application (2017-2022) & (KG)
Table 11. Global Levonorgestrel API Sales Market Share by Application (2017-2022)
Table 12. Global Levonorgestrel API Revenue by Application (2017-2022)
Table 13. Global Levonorgestrel API Revenue Market Share by Application (2017-2022)
Table 14. Global Levonorgestrel API Sale Price by Application (2017-2022) & (US$/G)
Table 15. Global Levonorgestrel API Sales by Company (2020-2022) & (KG)
Table 16. Global Levonorgestrel API Sales Market Share by Company (2020-2022)
Table 17. Global Levonorgestrel API Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Levonorgestrel API Revenue Market Share by Company (2020-2022)
Table 19. Global Levonorgestrel API Sale Price by Company (2020-2022) & (US$/G)
Table 20. Key Manufacturers Levonorgestrel API Producing Area Distribution and Sales Area
Table 21. Players Levonorgestrel API Products Offered
Table 22. Levonorgestrel API Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Levonorgestrel API Sales by Geographic Region (2017-2022) & (KG)
Table 26. Global Levonorgestrel API Sales Market Share Geographic Region (2017-2022)
Table 27. Global Levonorgestrel API Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Levonorgestrel API Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Levonorgestrel API Sales by Country/Region (2017-2022) & (KG)
Table 30. Global Levonorgestrel API Sales Market Share by Country/Region (2017-2022)
Table 31. Global Levonorgestrel API Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Levonorgestrel API Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Levonorgestrel API Sales by Country (2017-2022) & (KG)
Table 34. Americas Levonorgestrel API Sales Market Share by Country (2017-2022)
Table 35. Americas Levonorgestrel API Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Levonorgestrel API Revenue Market Share by Country (2017-2022)
Table 37. Americas Levonorgestrel API Sales by Type (2017-2022) & (KG)
Table 38. Americas Levonorgestrel API Sales Market Share by Type (2017-2022)
Table 39. Americas Levonorgestrel API Sales by Application (2017-2022) & (KG)
Table 40. Americas Levonorgestrel API Sales Market Share by Application (2017-2022)
Table 41. APAC Levonorgestrel API Sales by Region (2017-2022) & (KG)
Table 42. APAC Levonorgestrel API Sales Market Share by Region (2017-2022)
Table 43. APAC Levonorgestrel API Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Levonorgestrel API Revenue Market Share by Region (2017-2022)
Table 45. APAC Levonorgestrel API Sales by Type (2017-2022) & (KG)
Table 46. APAC Levonorgestrel API Sales Market Share by Type (2017-2022)
Table 47. APAC Levonorgestrel API Sales by Application (2017-2022) & (KG)
Table 48. APAC Levonorgestrel API Sales Market Share by Application (2017-2022)
Table 49. Europe Levonorgestrel API Sales by Country (2017-2022) & (KG)
Table 50. Europe Levonorgestrel API Sales Market Share by Country (2017-2022)
Table 51. Europe Levonorgestrel API Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Levonorgestrel API Revenue Market Share by Country (2017-2022)
Table 53. Europe Levonorgestrel API Sales by Type (2017-2022) & (KG)
Table 54. Europe Levonorgestrel API Sales Market Share by Type (2017-2022)
Table 55. Europe Levonorgestrel API Sales by Application (2017-2022) & (KG)
Table 56. Europe Levonorgestrel API Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Levonorgestrel API Sales by Country (2017-2022) & (KG)
Table 58. Middle East & Africa Levonorgestrel API Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Levonorgestrel API Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Levonorgestrel API Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Levonorgestrel API Sales by Type (2017-2022) & (KG)
Table 62. Middle East & Africa Levonorgestrel API Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Levonorgestrel API Sales by Application (2017-2022) & (KG)
Table 64. Middle East & Africa Levonorgestrel API Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Levonorgestrel API
Table 66. Key Market Challenges & Risks of Levonorgestrel API
Table 67. Key Industry Trends of Levonorgestrel API
Table 68. Levonorgestrel API Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Levonorgestrel API Distributors List
Table 71. Levonorgestrel API Customer List
Table 72. Global Levonorgestrel API Sales Forecast by Region (2023-2028) & (KG)
Table 73. Global Levonorgestrel API Sales Market Forecast by Region
Table 74. Global Levonorgestrel API Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Levonorgestrel API Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Levonorgestrel API Sales Forecast by Country (2023-2028) & (KG)
Table 77. Americas Levonorgestrel API Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Levonorgestrel API Sales Forecast by Region (2023-2028) & (KG)
Table 79. APAC Levonorgestrel API Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Levonorgestrel API Sales Forecast by Country (2023-2028) & (KG)
Table 81. Europe Levonorgestrel API Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Levonorgestrel API Sales Forecast by Country (2023-2028) & (KG)
Table 83. Middle East & Africa Levonorgestrel API Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Levonorgestrel API Sales Forecast by Type (2023-2028) & (KG)
Table 85. Global Levonorgestrel API Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Levonorgestrel API Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Levonorgestrel API Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Levonorgestrel API Sales Forecast by Application (2023-2028) & (KG)
Table 89. Global Levonorgestrel API Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Levonorgestrel API Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Levonorgestrel API Revenue Market Share Forecast by Application (2023-2028)
Table 92. ScinoPharm Basic Information, Levonorgestrel API Manufacturing Base, Sales Area and Its Competitors
Table 93. ScinoPharm Levonorgestrel API Product Offered
Table 94. ScinoPharm Levonorgestrel API Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 95. ScinoPharm Main Business
Table 96. ScinoPharm Latest Developments
Table 97. Altaris (3M Drug Delivery Systems) Basic Information, Levonorgestrel API Manufacturing Base, Sales Area and Its Competitors
Table 98. Altaris (3M Drug Delivery Systems) Levonorgestrel API Product Offered
Table 99. Altaris (3M Drug Delivery Systems) Levonorgestrel API Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 100. Altaris (3M Drug Delivery Systems) Main Business
Table 101. Altaris (3M Drug Delivery Systems) Latest Developments
Table 102. Bayer Basic Information, Levonorgestrel API Manufacturing Base, Sales Area and Its Competitors
Table 103. Bayer Levonorgestrel API Product Offered
Table 104. Bayer Levonorgestrel API Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 105. Bayer Main Business
Table 106. Bayer Latest Developments
Table 107. Cipla Basic Information, Levonorgestrel API Manufacturing Base, Sales Area and Its Competitors
Table 108. Cipla Levonorgestrel API Product Offered
Table 109. Cipla Levonorgestrel API Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 110. Cipla Main Business
Table 111. Cipla Latest Developments
Table 112. Formos Basic Information, Levonorgestrel API Manufacturing Base, Sales Area and Its Competitors
Table 113. Formos Levonorgestrel API Product Offered
Table 114. Formos Levonorgestrel API Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 115. Formos Main Business
Table 116. Formos Latest Developments
Table 117. FORTEQ NIDAU AG Basic Information, Levonorgestrel API Manufacturing Base, Sales Area and Its Competitors
Table 118. FORTEQ NIDAU AG Levonorgestrel API Product Offered
Table 119. FORTEQ NIDAU AG Levonorgestrel API Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 120. FORTEQ NIDAU AG Main Business
Table 121. FORTEQ NIDAU AG Latest Developments
Table 122. Gedeon Richter Basic Information, Levonorgestrel API Manufacturing Base, Sales Area and Its Competitors
Table 123. Gedeon Richter Levonorgestrel API Product Offered
Table 124. Gedeon Richter Levonorgestrel API Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 125. Gedeon Richter Main Business
Table 126. Gedeon Richter Latest Developments
Table 127. Hangzhou Longshine Bio-Tec Basic Information, Levonorgestrel API Manufacturing Base, Sales Area and Its Competitors
Table 128. Hangzhou Longshine Bio-Tec Levonorgestrel API Product Offered
Table 129. Hangzhou Longshine Bio-Tec Levonorgestrel API Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 130. Hangzhou Longshine Bio-Tec Main Business
Table 131. Hangzhou Longshine Bio-Tec Latest Developments
Table 132. Hubei Gedian Humanwell Pharmaceutical Basic Information, Levonorgestrel API Manufacturing Base, Sales Area and Its Competitors
Table 133. Hubei Gedian Humanwell Pharmaceutical Levonorgestrel API Product Offered
Table 134. Hubei Gedian Humanwell Pharmaceutical Levonorgestrel API Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 135. Hubei Gedian Humanwell Pharmaceutical Main Business
Table 136. Hubei Gedian Humanwell Pharmaceutical Latest Developments
Table 137. Indo Phyto Chemicals Basic Information, Levonorgestrel API Manufacturing Base, Sales Area and Its Competitors
Table 138. Indo Phyto Chemicals Levonorgestrel API Product Offered
Table 139. Indo Phyto Chemicals Levonorgestrel API Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 140. Indo Phyto Chemicals Main Business
Table 141. Indo Phyto Chemicals Latest Developments
Table 142. Industriale Chimica Basic Information, Levonorgestrel API Manufacturing Base, Sales Area and Its Competitors
Table 143. Industriale Chimica Levonorgestrel API Product Offered
Table 144. Industriale Chimica Levonorgestrel API Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 145. Industriale Chimica Main Business
Table 146. Industriale Chimica Latest Developments
Table 147. Jenapharm Basic Information, Levonorgestrel API Manufacturing Base, Sales Area and Its Competitors
Table 148. Jenapharm Levonorgestrel API Product Offered
Table 149. Jenapharm Levonorgestrel API Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 150. Jenapharm Main Business
Table 151. Jenapharm Latest Developments
Table 152. Lupin Basic Information, Levonorgestrel API Manufacturing Base, Sales Area and Its Competitors
Table 153. Lupin Levonorgestrel API Product Offered
Table 154. Lupin Levonorgestrel API Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 155. Lupin Main Business
Table 156. Lupin Latest Developments
Table 157. Naari Basic Information, Levonorgestrel API Manufacturing Base, Sales Area and Its Competitors
Table 158. Naari Levonorgestrel API Product Offered
Table 159. Naari Levonorgestrel API Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 160. Naari Main Business
Table 161. Naari Latest Developments
Table 162. Qinhuangdao Zizhu Pharmaceutical Basic Information, Levonorgestrel API Manufacturing Base, Sales Area and Its Competitors
Table 163. Qinhuangdao Zizhu Pharmaceutical Levonorgestrel API Product Offered
Table 164. Qinhuangdao Zizhu Pharmaceutical Levonorgestrel API Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 165. Qinhuangdao Zizhu Pharmaceutical Main Business
Table 166. Qinhuangdao Zizhu Pharmaceutical Latest Developments
Table 167. Sterling Chemical Malta Ltd Basic Information, Levonorgestrel API Manufacturing Base, Sales Area and Its Competitors
Table 168. Sterling Chemical Malta Ltd Levonorgestrel API Product Offered
Table 169. Sterling Chemical Malta Ltd Levonorgestrel API Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 170. Sterling Chemical Malta Ltd Main Business
Table 171. Sterling Chemical Malta Ltd Latest Developments
Table 172. Symbiotec Pharmalab Basic Information, Levonorgestrel API Manufacturing Base, Sales Area and Its Competitors
Table 173. Symbiotec Pharmalab Levonorgestrel API Product Offered
Table 174. Symbiotec Pharmalab Levonorgestrel API Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 175. Symbiotec Pharmalab Main Business
Table 176. Symbiotec Pharmalab Latest Developments
Table 177. Yangzhou Pharmaceutical Basic Information, Levonorgestrel API Manufacturing Base, Sales Area and Its Competitors
Table 178. Yangzhou Pharmaceutical Levonorgestrel API Product Offered
Table 179. Yangzhou Pharmaceutical Levonorgestrel API Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 180. Yangzhou Pharmaceutical Main Business
Table 181. Yangzhou Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Levonorgestrel API
Figure 2. Levonorgestrel API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Levonorgestrel API Sales Growth Rate 2017-2028 (KG)
Figure 7. Global Levonorgestrel API Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Levonorgestrel API Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Short-Acting Contraceptive API
Figure 10. Product Picture of Long-Acting Contraceptive API
Figure 11. Global Levonorgestrel API Sales Market Share by Type in 2021
Figure 12. Global Levonorgestrel API Revenue Market Share by Type (2017-2022)
Figure 13. Levonorgestrel API Consumed in Table
Figure 14. Global Levonorgestrel API Market: Table (2017-2022) & (KG)
Figure 15. Levonorgestrel API Consumed in Mixture Products
Figure 16. Global Levonorgestrel API Market: Mixture Products (2017-2022) & (KG)
Figure 17. Levonorgestrel API Consumed in Other
Figure 18. Global Levonorgestrel API Market: Other (2017-2022) & (KG)
Figure 19. Global Levonorgestrel API Sales Market Share by Application (2017-2022)
Figure 20. Global Levonorgestrel API Revenue Market Share by Application in 2021
Figure 21. Levonorgestrel API Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Levonorgestrel API Revenue Market Share by Company in 2021
Figure 23. Global Levonorgestrel API Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Levonorgestrel API Revenue Market Share by Geographic Region in 2021
Figure 25. Global Levonorgestrel API Sales Market Share by Region (2017-2022)
Figure 26. Global Levonorgestrel API Revenue Market Share by Country/Region in 2021
Figure 27. Americas Levonorgestrel API Sales 2017-2022 (KG)
Figure 28. Americas Levonorgestrel API Revenue 2017-2022 ($ Millions)
Figure 29. APAC Levonorgestrel API Sales 2017-2022 (KG)
Figure 30. APAC Levonorgestrel API Revenue 2017-2022 ($ Millions)
Figure 31. Europe Levonorgestrel API Sales 2017-2022 (KG)
Figure 32. Europe Levonorgestrel API Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Levonorgestrel API Sales 2017-2022 (KG)
Figure 34. Middle East & Africa Levonorgestrel API Revenue 2017-2022 ($ Millions)
Figure 35. Americas Levonorgestrel API Sales Market Share by Country in 2021
Figure 36. Americas Levonorgestrel API Revenue Market Share by Country in 2021
Figure 37. United States Levonorgestrel API Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Levonorgestrel API Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Levonorgestrel API Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Levonorgestrel API Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Levonorgestrel API Sales Market Share by Region in 2021
Figure 42. APAC Levonorgestrel API Revenue Market Share by Regions in 2021
Figure 43. China Levonorgestrel API Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Levonorgestrel API Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Levonorgestrel API Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Levonorgestrel API Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Levonorgestrel API Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Levonorgestrel API Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Levonorgestrel API Sales Market Share by Country in 2021
Figure 50. Europe Levonorgestrel API Revenue Market Share by Country in 2021
Figure 51. Germany Levonorgestrel API Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Levonorgestrel API Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Levonorgestrel API Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Levonorgestrel API Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Levonorgestrel API Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Levonorgestrel API Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Levonorgestrel API Revenue Market Share by Country in 2021
Figure 58. Egypt Levonorgestrel API Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Levonorgestrel API Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Levonorgestrel API Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Levonorgestrel API Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Levonorgestrel API Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Levonorgestrel API in 2021
Figure 64. Manufacturing Process Analysis of Levonorgestrel API
Figure 65. Industry Chain Structure of Levonorgestrel API
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...